Aclarion, Inc. (ACON)
NASDAQ: ACON · IEX Real-Time Price · USD
0.305
+0.015 (5.14%)
Jul 22, 2024, 11:17 AM EDT - Market open
Aclarion Employees
As of December 31, 2023, Aclarion had 6 total employees, including 4 full-time and 2 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
$10,008
Profits / Employee
-$1,021,169
Market Cap
2.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| cbdMD | 52 |
| Tenon Medical | 21 |
| Catheter Precision | 14 |
| InMed Pharmaceuticals | 13 |
| Cyclacel Pharmaceuticals | 12 |
| Heart Test Laboratories | 12 |
| Entero Therapeutics | 9 |
| Phio Pharmaceuticals | 9 |
ACON News
- 13 days ago - Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK - GlobeNewsWire
- 26 days ago - Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK - GlobeNewsWire
- 27 days ago - Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London - GlobeNewsWire
- 3 months ago - Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain - GlobeNewsWire
- 5 months ago - Aclarion Announces Closing of $3.0 Million Public Offering - GlobeNewsWire
- 5 months ago - Aclarion Announces Pricing of $3.0 Million Public Offering - GlobeNewsWire
- 6 months ago - Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership - GlobeNewsWire
- 6 months ago - Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD - GlobeNewsWire